Capital
Capital Solutions in the New Health
Today’s bio pharma companies are under increased pressure to:
- Speed drug development and commercialization
- Meet demanding regulatory requirements
- Access resistant markets and;
- Maximize value across the product lifecycle – while reducing financial and operational risks
You need an ally with global reach, broad experience and scientific expertise who can expand opportunities and mitigate risk strategically and operationally.
As a fully integrated bio pharma services company, Quintiles ensures alignment with sponsor needs by defining shared goals, risks and rewards, and implementing proven governance principles that deliver innovative, cost-effective solutions.
Innovative Alliances
We leverage our intellectual, human and financial capital to advance mutual interests and accomplish shared goals.
Quintiles:
- Has more than $2.4 billion in investment commitments
- Drives 80+ non-traditional alliances;
- Manages over 4,000 employees for our partners
We’re as motivated to achieve goals as you are with -
Intellectual Capital – With an integrated approach, we work with you to solve business challenges and shape programs with less risk and variability, and a greater likelihood of success.
Human Capital – We can optimize drug development and drive commercial success with the thousands of clinical and commercial experts across therapeutic disciplines around the world.
Financial Capital – As your partner we invest our financial resources into your programs, as well as find and manage interested capital partners.
- Partnership Structures
-
Support your business initiative with resources and expertise.
- Late Phase
-
Demonstrate product benefits and monitor safety in larger populations with cost-effective study design and execution.
- Alliance Management
-
Transform large fixed costs into variable as-needed resources.
- Partnership Case Studies
-
These case studies demonstrate just a few of our innovative solutions that go beyond the traditional fee-for-service model.
